A股异动丨乾照光电(300102.SZ)大跌9.57% 大股东忙减持
格隆汇9月11日丨近两个交易日累跌逾26%的乾照光电(300102.SZ)仍未止跌,现大跌9.57%,此前沾上“第三代半导体”热点的乾照光电走出6个交易日实现翻倍的行情。乾照光电9月8日晚披露了两个减持公告。其一,大股东阵营的一致行动人紫金15号卓丰增持集合资金信托计划当天通过集中竞价方式累计减持1430万股,占公司总股本的2.02%,所持全部股份一日售罄。其二,单一第一大股东南烨实业于9月8日通过大宗交易方式累计减持公司股份2815万股,占公司总股本的3.98%。福建卓丰投资合伙企业于9月9日再度减持公司股份,减持股数1559.041万股,减持比例2.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.